Intercellular propagation of extracellular signal-regulated kinase activation revealed by in vivo imaging of mouse skin

eLife

Volumn 2015, Issue 4, 2015, Pages

  Hiratsuka, Toru ^a   Fujita, Yoshihisa ^a   Naoki, Honda ^a   Aoki, Kazuhiro ^a   Kamioka, Yuji ^a   Matsuda, Michiyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; LIGAND; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE PROGRESSION; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYMIC BIOSENSOR; EPIDERMIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GROWTH REGULATION; IMAGING; MONTE CARLO METHOD; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE CELL ANALYSIS; TIME LAPSE IMAGING; TRANSGENIC MOUSE; WOUND HEALING; ANIMAL; CELL CYCLE; DRUG EFFECTS; EAR; ENZYMOLOGY; EXTRACELLULAR SPACE; HUMAN; METABOLISM; SKIN; THREE DIMENSIONAL IMAGING;

MUS;

ANIMALS; CELL CYCLE; CELL DIVISION; EAR; ENZYME ACTIVATION; EPIDERMIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; EXTRACELLULAR SPACE; HUMANS; IMAGING, THREE-DIMENSIONAL; LIGANDS; MATRIX METALLOPROTEINASE INHIBITORS; MICE, TRANSGENIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; SINGLE-CELL ANALYSIS; SKIN; TETRADECANOYLPHORBOL ACETATE; WOUND HEALING;

EID: 84922896900     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.05178     Document Type: Article

References (32)

1. Abel EL, Angel JM, Kiguchi K, DiGiovanni J. 2009. Multi-stage chemical carcinogenesis in mouse skin: fundamen­tals and applications. Nature Protocols 4:1350–1362. doi: 10.1038/nprot.2009.120.
2. Albeck JG, Mills GB, Brugge JS. 2013. Frequency-modulated pulses of ERK activity transmit quantitative proliferation signals. Molecular Cell 49:249–261. doi: 10.1016/j.molcel.2012.11.002.
3. Aoki K, Kumagai Y, Sakurai A, Komatsu N, Fujita Y, Shionyu C, Matsuda M. 2013. Stochastic ERK activation induced by noise and cell-to-cell propagation regulates cell density-dependent proliferation. Molecular Cell 52:529–540. doi: 10.1016/j.molcel.2013.09.015.
4. Aoki K, Matsuda M. 2009. Visualization of small GTPase activity with fluorescence resonance energy transfer-based biosensors. Nature Protocols 4:1623–1631. doi: 10.1038/nprot.2009.175.
5. Arwert EN, Hoste E, Watt FM. 2012. Epithelial stem cells, wound healing and cancer. Nature Reviews Cancer 12:170–180. doi: 10.1038/nrc3217.
6. Blanpain C, Fuchs E. 2014. Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration. Science 344:1242281. doi: 10.1126/science.1242281.
7. Chambard JC, Lefloch R, Pouysségur J, Lenormand P. 2007. ERK implication in cell cycle regulation. Biochimica Et Biophysica Acta 1773:1299–1310. doi: 10.1016/j.bbamcr.2006.11.010.
8. Dangi S, Chen FM, Shapiro P. 2006. Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21 CIP1. Cell Proliferation 39:261–279. doi: 10.1111/j.1365-2184.2006.00388.x.
9. Dethlefsen SM, Raab G, Moses MA, Adam RM, Klagsbrun M, Freeman MR. 1998. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. Journal of Cellular Biochemistry 69:143–153. doi: 10.1002/(SICI)1097-4644(19980501)69:23.0.CO;2-S.
10. Franzke CW, Cobzaru C, Triantafyllopoulou A, Löffek S, Horiuchi K, Threadgill DW, Kurz T, van Rooijen N, Bruckner-Tuderman L, Blobel CP. 2012. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. The Journal of Experimental Medicine 209:1105–1119. doi: 10.1084/jem.20112258.
11. Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K, Tamai Y, Kurisaki T, Sehara-Fujisawa A, Ohno S, Mekada E. 1998. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. The EMBO Journal 17:7260–7272. doi: 10.1093/emboj/17.24.7260.
12. Jones PH, Harper S, Watt FM. 1995. Stem cell patterning and fate in human epidermis. Cell 80:83–93. doi: 10.1016/0092-8674(95)90453-0.
13. Kamioka Y, Sumiyama K, Mizuno R, Sakai Y, Hirata E, Kiyokawa E, Matsuda M. 2012. Live imaging of protein kinase activities in transgenic mice expressing FRET biosensors. Cell Structure and Function 37:65–73. doi: 10.1247/csf.11045.
14. Khavari TA, Rinn J. 2007. Ras / Erk MAPK signaling in epidermal homeostasis and neoplasia. Cell Cycle 6:2928–2931. doi: 10.4161/cc.6.23.4998.
15. Kholodenko BN. 2006. Cell-signalling dynamics in time and space. Nature Reviews Molecular Cell Biology 7:165–176. doi: 10.1038/nrm1838.
16. Le Gall SM, Auger R, Dreux C, Mauduit P. 2003. Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. The Journal of Biological Chemistry 278:45255–45268. doi: 10.1074/jbc.M307745200.
17. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC. 1993. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263–278. doi: 10.1016/0092-8674(93)90228-I.
18. Massagué J, Pandiella A. 1993. Membrane-anchored growth factors. Annual Review of Biochemistry 62:515–541. doi: 10.1146/annurev.bi.62.070193.002503.
19. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA. 1998. An essential role for ectodomain shedding in mammalian development. Science 282:1281–1284. doi: 10.1126/science.282.5392.1281.
20. Pouysségur J, Volmat V, Lenormand P. 2002. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochemical Pharmacology 64:755–763. doi: 10.1016/S0006-2952(02)01135-8.
21. Rahmouni S, Cerignoli F, Alonso A, Tsutji T, Henkens R, Zhu C, Louis-dit-Sully C, Moutschen M, Jiang W, Mustelin T. 2006. Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence. Nature Cell Biology 8:524–531. doi: 10.1038/ncb1398.
22. Roberts PJ, Der CJ. 2007. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26:3291–3310. doi: 10.1038/sj.onc.1210422.
23. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. The Journal of Cell Biology 164:769–779. doi: 10.1083/jcb.200307137.
24. Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, Imamura T, Ogawa M, Masai H, Miyawaki A. 2008. Visualizing spatiotemporal dynamics of multicellu­lar cell-cycle progression. Cell 132:487–498. doi: 10.1016/j.cell.2007.12.033.
25. Schneider MR, Werner S, Paus R, Wolf E. 2008. Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology. The American Journal Of Pathology 173:14–24. doi: 10.2353/ajpath.2008.070942.
26. Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M. 2007. The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 75:770–787. doi: 10.1111/j.1432-0436.2007.00238.x.
27. Tamemoto H, Kadowaki T, Tobe K, Ueki K, Izumi T, Chatani Y, Kohno M, Kasuga M, Yazaki Y, Akanuma Y. 1992. Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells. The Journal of Biological Chemistry 267:20293–20297.
28. Torii S, Yamamoto T, Tsuchiya Y, Nishida E. 2006. ERK MAP kinase in G cell cycle progression and cancer. Cancer Science 97:697–702. doi: 10.1111/j.1349-7006.2006.00244.x.
29. Wright JH, Munar E, Jameson DR, Andreassen PR, Margolis RL, Seger R, Krebs EG. 1999. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proceedings of the National Academy of Sciences of USA 96:11335–11340. doi: 10.1073/pnas.96.20.11335.
30. Yan Y, Spieker RS, Kim M, Stoeger SM, Cowan KH. 2005. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation. Oncogene 24:3285–3296. doi: 10.1038/sj.onc.1208492.
31. Yuspa SH. 1994. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis −− thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Research 54:1178–1189.
32. Zwang Y, Sas-Chen A, Drier Y, Shay T, Avraham R, Lauriola M, Shema E, Lidor-Nili E, Jacob-Hirsch J, Amariglio N, Lu Y, Mills GB, Rechavi G, Oren M, Domany E, Yarden Y. 2011. Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals. Molecular Cell 42:524–535. doi: 10.1016/j.molcel.2011.04.017.